EUVIMEDEUVIMED entdecken
Crossref

Corylifol a alleviates lipopolysaccharide-induced inflammation by targeting and inhibiting IκBα phosphorylation

Yanxuan Hu, Xiangrong Feng, Xibao Zhao, Xucan Huang, Yunjian Wang, Yufeng Fu, Yue Xiao, Han Wu, Qianqian Di

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.117203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Yanxuan Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China. Hauptthemen laut MEDLINE: NF-KappaB Inhibitor alpha, Anti-Inflammatory Agents, Macrophages, Inflammation. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Guangdong Provincial Natural Science Foundation, Shenzhen Municipality Medical Information Center, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-KappaB Inhibitor alphaAnti-Inflammatory AgentsMacrophagesInflammationEndotoxemiaFlavonoidsAnimalsLipopolysaccharidesPhosphorylationMiceMice, Inbred C57BLNF-kappa BCytokinesRAW 264.7 CellsHumansMaleI-kappa B Kinase

Stichwörter der Autor:innen

Corylifol aEndotoxemiaInflammationIκBαNF-κB

Substanzen

LipopolysaccharidesNF-KappaB Inhibitor alphaAnti-Inflammatory AgentsNF-kappa BCytokinesNfkbia protein, mouseI-kappa B KinaseFlavonoids

Autor:innen und Institutionen

  • School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China.
  • Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, Marshall Laboratory of Biomedical Engineering, Institute of Biological Therapy, Shenzhen University Medical School, Shenzhen University, Shenzh…

Förderung

  • Guangdong Provincial Natural Science Foundation
  • Shenzhen Municipality Medical Information Center
  • National Natural Science Foundation of China

Zitieren

APA

Hu, Y., Feng, X., Zhao, X., Huang, X., Wang, Y., Fu, Y., Xiao, Y., Wu, H., & Di, Q. (2026). Corylifol a alleviates lipopolysaccharide-induced inflammation by targeting and inhibiting IκBα phosphorylation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117203

Vancouver

Hu Y, Feng X, Zhao X, Huang X, Wang Y, Fu Y, et al. Corylifol a alleviates lipopolysaccharide-induced inflammation by targeting and inhibiting IκBα phosphorylation. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117203

BibTeX
@article{Hu2026,
  author = {Hu, Yanxuan and Feng, Xiangrong and Zhao, Xibao and Huang, Xucan and Wang, Yunjian and Fu, Yufeng and Xiao, Yue and Wu, Han and Di, Qianqian},
  title = {Corylifol a alleviates lipopolysaccharide-induced inflammation by targeting and inhibiting IκBα phosphorylation},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.117203}
}
Kostenlos starten →